New gene clue to metastasis

British researchers have discovered more than 20 genes linked to cancer metastasis, it was announced last night.

This included a single gene, known as Spns2, that could reduce the spread of cancer by 75% when deactivated, according to the findings published in Nature.

The research was led by the Wellcome Trust Sanger Institute in Cambridge, UK.

The researchers screened some 810 genes in genetically-modified mice and found 23 that increased or decreased the spread of skin tumour cells to the lung.

The study found that removing the Spns gene reduced metastasis in cancers of the skin, colon, lung and breast.

The gene was known to have a role in the immune system before the latest discoveries.

Researcher Dr David Adams said: “This work supports the emerging area of immunotherapy, where the bodies’ own immune system is harnessed to fight cancer.

"Drugs could be designed to bind to the S1P transporter, preventing it from working and causing advantageous changes to the immune system.

"Investigation of further targets in the Spns2 pathway, or other targets identified in this study could help develop potential therapies.”

Louise van der Weyden et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature 11 January 2017; doi:10.1038/nature20792

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index